Fondaparinux: a Factor Xa inhibitor for antithrombotic therapy

By Turpie Alexander GG  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 6, 2004-06 ,pp. : 1373-1384

Informa Healthcare

Access to resources Recommend Favorite

Antithrombotic effect of a novel protein from Fusarium sp. CPCC 480097 in a rat model of artery-vein bypass thrombosis

By Wu Bin   Xu Jiaxing  

Pharmaceutical Biology (Formerly International Journal of Pharmacognosy), Vol. 50, Iss. 7, 2012-07 ,pp. : 866-870

Informa Healthcare

Access to resources Recommend Favorite

Relationship between the antithrombotic effect of YM-75466, a novel factor Xa inhibitor, and coagulation parameters in rats

By Sato K.   Taniuchi Y.   Kawasaki T.   Hirayama F.   Koshio H.   Matsumoto Y.  

European Journal of Pharmacology, Vol. 347, Iss. 2, 1998-04 ,pp. : 231-236

Elsevier

Access to resources Recommend Favorite

YM-60828, a novel factor Xa inhibitor: Separation of its antithrombotic effects from its prolongation of bleeding time

By Sato K.   Kawasaki T.   Taniuchi Y.   Hirayama F.   Koshio H.   Matsumoto Y.  

European Journal of Pharmacology, Vol. 339, Iss. 2, 1997-11 ,pp. : 141-146

Elsevier

Access to resources Recommend Favorite

Molecular model of an interaction between factor Xa and DX-9065a, a novel factor Xa inhibitor: contribution of the acetimidoylpyrrolidine moiety of the inhibitor to potency and selectivity for serine proteases

By Katakura S.   Nagahara T.   Hara T.   Kunitada S.   Iwamoto M.  

European Journal of Medicinal Chemistry, Vol. 30, Iss. 5, 1995-01 ,pp. : 387-394

Elsevier

Access to resources Recommend Favorite